NEW YORK, April 27 – Following a trend that is becoming common on Wall Street these days, Packard Bioscience has withdrawn a planned follow-on offering of 10 million shares of its common stock, the company said Friday.

This announcement comes after Packard indefinitely postponed its follow-on offering March 29. At the time, the company said it would continue to monitor market conditions to determine a suitable time for the offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.